Portfolio company
CytoTerra
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops next-generation sequencing assays to detect chromosomal abnormalities for clinical researchers and healthcare providers specialising in oncology and genetic diseases.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Ultima Genomics
This company develops and manufactures high-throughput DNA sequencing platforms for researchers and clinicians performing population-scale genomic analysis.
3X Genetics
This company develops long-read genetic testing technology and diagnostics for biopharma companies to identify patients with rare repeat expansion disorders.
Single molecule diagnostics
This company develops prenatal screening and oncology liquid biopsy tests for clinicians to identify genetic risks and monitor cancer treatments in patients.
Arima Genomics
This company develops 3D genomic sequencing kits and clinical diagnostic tests for researchers and pharmaceutical companies to identify cancer-driving genetic alterations.
Cytox
This company develops non-invasive genetic tests for Alzheimer's disease risk assessment and patient stratification for clinicians and pharmaceutical researchers.
Genetic Sequencing
This company develops nanopore-based technology for DNA sequencing to support researchers and clinicians in medical diagnostics and genomic analysis.
BioSkryb
This company develops genomic amplification and sequencing systems for researchers and clinicians to analyse DNA and RNA from single cells.
BillionToOne
This company develops molecular diagnostic tests for prenatal screening and oncology care to help clinicians and patients identify genetic conditions and monitor cancer.
